Page last updated: 2024-08-23

raloxifene hydrochloride and Ischemic Attack, Transient

raloxifene hydrochloride has been researched along with Ischemic Attack, Transient in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, PW; Barrett-Connor, E; Cox, DA; Grady, D; Harper, KD; Hoszowski, K; Rautaharju, P; Sashegyi, A	1

Trials

1 trial(s) available for raloxifene hydrochloride and Ischemic Attack, Transient

Article	Year
Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA, 2002, Feb-20, Volume: 287, Issue:7 Topics: Aged; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Ischemic Attack, Transient; Lipoproteins; Myocardial Ischemia; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators; Stroke; Survival Analysis	2002

Article

Year

Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial.

JAMA, 2002, Feb-20, Volume: 287, Issue:7

Topics: Aged; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Ischemic Attack, Transient; Lipoproteins; Myocardial Ischemia; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators; Stroke; Survival Analysis

2002